Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Gains from Investment Securities (2016 - 2026)

Seres Therapeutics (MCRB) has disclosed Gains from Investment Securities for 11 consecutive years, with $68596.0 as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A to $68596.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 million through Dec 2025, up 66.06% year-over-year, with the annual reading at $1.1 million for FY2025, 26.87% up from the prior year.
  • Gains from Investment Securities hit $68596.0 in Q3 2025 for Seres Therapeutics, down from $1.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.4 million in Q1 2022 to a low of -$3.4 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $431143.9 across 5 years, with a median of $174675.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: crashed 2925.89% in 2022 and later skyrocketed 1329.83% in 2023.
  • Year by year, Gains from Investment Securities stood at -$112000.0 in 2021, then plummeted by 2925.89% to -$3.4 million in 2022, then soared by 54.15% to -$1.6 million in 2023, then soared by 114.74% to $229000.0 in 2024, then crashed by 70.05% to $68596.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for MCRB at $68596.0 in Q3 2025, $1.2 million in Q2 2025, and $477431.0 in Q1 2025.